not logged in

European Urology

European Urology

Volume 55, issue 1, pages 1-260, January 2009

Review Articles and Original Articles together with the corresponding Full Length Editorials

Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881

Jan H.M. Blom, Hein van Poppel, Jean M. Maréchal, Didier Jacqmin, Fritz H. Schröder, Linda de Prijck and Richard Sylvester for the EORTC Genitourinary Tract Cancer Group.

Accepted 23 September 2008, Published online 1 October 2008, pages 28 - 34


Abstract

Background

Until now the therapeutic value of lymphadenectomy for renal-cell carcinoma has remained controversial. Several studies attempting to solve this controversy have been published, but none of them were set up as prospective randomized trials.

Objective

To assess whether a complete lymph-node dissection in conjunction with a radical nephrectomy for renal-cell cancer is more effective than a radical nephrectomy alone.

Design, setting, and participants

In 1988, the European Organization for Research and Treatment of Cancer (EORTC) Genitourinary Group started a randomized phase 3 trial comparing radical nephrectomy with a complete lymphadenectomy to radical nephrectomy alone. After the renal-cell carcinoma was judged to be N0M0 and resectable, patients were randomly selected prior to surgery to undergo either a radical nephrectomy with a complete lymph-node dissection or to undergo a radical nephrectomy alone. Postoperatively all patients were followed for progression of disease and mortality.

Intervention

All patients underwent a radical nephrectomy with or without a complete lymph-node dissection.

Measurements

All patients were postoperatively evaluated for time-to-progression, overall survival, and progression-free survival. Time-to-event curves were estimated based on the Kaplan-Meier method and compared using a two-sided log-rank test.

Results and limitations

Of the 772 patients selected for randomization, 40 were not eligible for the study. 383 patients were randomly selected to receive a complete lymph-node dissection together with a radical nephrectomy, and 389 patients were randomly selected to undergo a radical nephrectomy alone. The complication rate did not differ significantly between the two groups. Complete lymph-node dissections in 346 patients revealed an absence of lymph-node metastases in 332 patients. The study revealed no significant differences in overall survival, time to progression of disease, or progression-free survival between the two study groups.

Conclusions

This study shows that, after proper preoperative staging, the incidence of unsuspected lymph-node metastases is low (4.0%) and that, notwithstanding a possible relationship to this low incidence rate, no survival advantage of a complete lymph-node dissection in conjunction with a radical nephrectomy could be demonstrated.

Take Home Message

This study shows that in localized renal-cell cancer (stage T1–3N0M0), the risk of unsuspected lymph-node metastases is very low. A routine lymphadenectomy during nephrectomy did not result in a survival advantage in this prospective randomized trial.

Keywords: Renal cell cancer, Radical nephrectomy, Lymph-node dissection, Lymph-node metastases, Survival.


Recommend this article

Currently this article has a rating of 0. Please log in to recommend it.